Cargando…

Effect of Dapagliflozin on Exercise Capacity and Cardiovascular Risk in Patients with Heart Failure

Heart failure (HF) is a serious disorder that affects millions of people worldwide, with a high rate of exercise intolerance, rehospitalization, and death. HF has many underlying causes, including type 2 diabetes mellitus (T2DM), which corresponds with high mortality and short survival among patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nazer, Rakan, Albratty, Mohammed, Aldhahi, Monira I., Alqurashy, Maiasa, Halawi, Maryam A., Albarrati, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690048/ https://www.ncbi.nlm.nih.gov/pubmed/36360474 http://dx.doi.org/10.3390/healthcare10112133

Ejemplares similares

Exercise Capacity Is Independent of Respiratory Muscle Strength in Patients with Chronic Heart Failure
por: Albarrati, Ali, et al.
Publicado: (2022)

Measurement Properties of the Duke Activity Status Index in Arab Patients with Cardiovascular Disease
por: Albarrati, Ali, et al.
Publicado: (2022)

Impact of Psychological Factors on Functional Performance among Patients with Chronic Obstructive Pulmonary Disease
por: Aldhahi, Monira I., et al.
Publicado: (2023)

The brain‐before‐heart strategy for coronary artery bypass grafting in the severely atherosclerotic aorta: A single‐institution experience
por: Nazer, Rakan I., et al.
Publicado: (2022)

Reliability and Validity of Kansas City Cardiomyopathy Questionnaire in Arabic Patients with Chronic Heart Failure
por: Albarrati, Ali M., et al.
Publicado: (2023)

Dapagliflozin Impact on the Exercise Capacity of Non-Diabetic Heart Failure with Reduced Ejection Fraction Patients
por: Reis, João, et al.
Publicado: (2022)

Effectiveness of Low to Moderate Physical Exercise Training on the Level of Low-Density Lipoproteins: A Systematic Review
por: Albarrati, Ali M., et al.
Publicado: (2018)

Repair of coronary sinus shear stress injury following blunt chest trauma using adenosine-induced asystole
por: Nazer, Rakan I, et al.
Publicado: (2022)

Current Status of Dapagliflozin in Congestive Heart Failure
por: Palandurkar, Gopal, et al.
Publicado: (2022)

Effect of Weight Self-Stigma and Self-Esteem on Aerobic Exercise Capacity in Adult Women with Different Body Compositions
por: Aldhahi, Monira I., et al.
Publicado: (2022)

The insufficiency of recreational exercises in improving cardiovascular fitness: an investigation of ventricular systolic and diastolic parameters and left atrial mechanical functions
por: Akgümüş, Alkame, et al.
Publicado: (2023)

Different Continuous Training Intensities Improve Echocardiographic Parameters, Quality of Life, and Functional Capacity in Heart Failure Patients with Reduced Ejection Fraction
por: Abdeen, Heba A, et al.
Publicado: (2023)

The effect of Dapagliflozin on renal functions in hospitalized patients with Acute Heart Failure
por: Gilani, Syedah Fauzia Fatima, et al.
Publicado: (2023)

The Role of Dapagliflozin in the Management of Heart Failure: An Update on the Emerging Evidence
por: Gupta, Manasvi, et al.
Publicado: (2021)

Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics
por: Yeoh, Su Ern, et al.
Publicado: (2023)

Effect of Gait Alteration on Fatigability during Walking in Adult Women with High Body Fat Composition
por: Aldhahi, Monira I.
Publicado: (2022)

Theranostic Nanomedicines for the Treatment of Cardiovascular and Related Diseases: Current Strategies and Future Perspectives
por: Manners, Natasha, et al.
Publicado: (2022)

Effect of Dapagliflozin in Patients with Heart Failure: A Systematic Review and Meta-Analysis
por: Ali, Ahmed E., et al.
Publicado: (2023)

Impact of Dapagliflozin on the Left Ventricular Diastolic Function in Diabetic Patients with Heart Failure Complicating Cardiovascular Risk Factors
por: Soga, Fumitaka, et al.
Publicado: (2021)

Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF
por: Jhund, Pardeep S., et al.
Publicado: (2021)

Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
por: Docherty, Kieran F, et al.
Publicado: (2020)

Dapagliflozin for Heart Failure with Preserved Ejection Fraction: Will the DELIVER Study Deliver?
por: Williams, David M., et al.
Publicado: (2020)

Cost-effectiveness of Dapagliflozin for the Treatment of Heart Failure With Reduced Ejection Fraction
por: Isaza, Nicolas, et al.
Publicado: (2021)

Dapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction
por: Blair, Hannah A.
Publicado: (2021)

Eligibility of Dapagliflozin and Empagliflozin in a Real-World Heart Failure Population
por: Håkansson, Erik, et al.
Publicado: (2021)

Dapagliflozin for heart failure according to body mass index: the DELIVER trial( )
por: Adamson, Carly, et al.
Publicado: (2022)

Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)
por: Serenelli, Matteo, et al.
Publicado: (2020)

Comparative effectiveness of 10-week equipment-based pilates and diaphragmatic breathing exercise on heart rate variability and pulmonary function in young adult healthy women with normal BMI – a quasi-experimental study
por: Adıgüzel, Songül, et al.
Publicado: (2023)

A cross-sectional study explores the association of physical activity with the severity of peripheral arterial disease from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
por: Aldhahi, Monira I., et al.
Publicado: (2022)

Dapagliflozin in Patients with Chronic Heart Failure: A Systematic Review and Meta-Analysis
por: Cai, Ru-ping, et al.
Publicado: (2021)

The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context
por: McMurray, John J V, et al.
Publicado: (2020)

Economic Evaluation of Dapagliflozin in the Treatment of Patients With Heart Failure: A Systematic Review
por: Wu, Meiyu, et al.
Publicado: (2022)

Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF
por: Docherty, Kieran F., et al.
Publicado: (2022)

Dapagliflozin and Empagliflozin in Heart Failure with Reduced Ejection Fraction: A Retrospective Study
por: Hao, Zhengyang, et al.
Publicado: (2022)

Dapagliflozin initiation in chronic heart failure patients improves central sleep apnoea
por: Jaffuel, Dany, et al.
Publicado: (2023)

Dapagliflozin-affected endothelial dysfunction and altered gut microbiota in mice with heart failure
por: Bao, Nandi, et al.
Publicado: (2023)

Gender related predictors of limited exercise capacity in heart failure
por: Bajraktari, Gani, et al.
Publicado: (2013)

Spiral aortoplasty for dilated ascending aorta: a new technique for high-risk patients with combined procedures
por: Nazer, Rakan I.
Publicado: (2019)

Atrial septal defect closure in a young patient presenting with recurrent cryptogenic stroke: a case report
por: Nazer, Rakan I.
Publicado: (2020)

Outbreak of Middle East Respiratory Syndrome-Coronavirus Causes High Fatality After Cardiac Operations
por: Nazer, Rakan I.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5rrutpi12lt1r0n7bar1i7hccm